ARVN NASDAQ
Credit Risk of going bust: lower than 89% of companies Debt: 1.7% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), Arvinas, Inc. would be worth roughly what it owes.
Total debt $8.2M against a stock market value of $471.6M.
Distance to default 12.88 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $350K (short-term plus half of long-term), stock volatility 55.1%; Altman Z'' 3.51. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
New Haven, CT 06511
US
Arvinas, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to identifying, advancing, and marketing innovative therapies designed to eliminate disease-causing proteins. The company's pipeline features several promising candidates. These include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader, currently in Phase I clinical trials, which specifically targets the androgen receptor (AR) protein to treat metastatic castration-resistant prostate cancer (mCRPC) in men. Another key PROTAC protein degrader is ARV-471, which targets the estrogen receptor protein for patients suffering from metastatic ER-positive/HER2-negative breast cancer. Furthermore, Arvinas is developing ARV-766, an investigational orally bioavailable PROTAC protein degrader also aimed at treating mCRPC in men. The company has strategic alliances with major pharmaceutical entities including Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Founded in 2013, Arvinas, Inc. is headquartered in New Haven, Connecticut.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Smaldone Alsup Lauri | A-Award | 15,527 | — | 2026-06-24 |
| Smaldone Alsup Lauri | A-Award | 22,714 | $8.05 | 2026-06-24 |
| Norwalk Leslie V | A-Award | 15,527 | — | 2026-06-24 |
| Norwalk Leslie V | A-Award | 22,714 | $8.05 | 2026-06-24 |
| Morrison Briggs | A-Award | 15,527 | — | 2026-06-24 |